Pediatric DisorderNCT04643015
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
An observational study of Pediatric Disorder and Adult Disease, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
Trial summary
This study is being done to see how we can prevent problems caused by movement during the MRI scan. Different ways of doing the scan (techniques) will be tested to see if they are practical and can prevent problems related to motion. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Pediatric Disorder, Adult Disease
- What is being tested?
- MRI
- How many people
- 21 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Nov 2020to 18 Nov 2026
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Potential research subjects will be identified by a member of the patient's treatment team, the protocol investigator, or research team at Memorial Sloan-Kettering Cancer Center (MSK). With consultation of the clinical team, the investigator or a consenting professional from the research team will go to the treating physician's clinic to discuss the study and consent the patient in person.
Who may be able to join
- Patients of any age, including males and females, who are being treated in the Department of Pediatrics and are already scheduled to undergo MRI
Who cannot join
- Anyone who would normally be excluded from undergoing an MRI examination as per Memorial Hospital for Cancer and Allied Diseases Screening Questionnaire for MRI (Appendix A). Subjects with pacemakers or aneurysm clips that are MRI conditional or MRI compatible may enroll in the study if the study is clinically indicated.
- Female patients who are pregnant
- Patients who are unable to comply or complete the MRI exam due to claustrophobia or high levels of anxiety
- Patients at higher risk due to age, frailty, or the emergent nature of their condition
- Patients who are undergoing MRI only of the head, neck or spine
Trial locations and contacts
1 site in 1 country.
United States1 site
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
About this study
Official title: New Image Techniques for Magnetic Resonance Imaging in Children and Adults
This study is being done to see how we can prevent problems caused by movement during the MRI scan. Different ways of doing the scan (techniques) will be tested to see if they are practical and can prevent problems related to motion. For example, changes in the timing of the magnetic field and the radio waves will be examined, and at changes in the way a computer is used to process the images. The new techniques will be compared with the techniques that are usually used.
- Conditions
- Pediatric Disorder, Adult Disease
- Being tested
- MRI
- Keywords
- Magnetic Resonance Imaging, MRI, 20-482, Memorial Sloan Kettering Cancer Center
- Medical subject headings
- Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MRIDiagnostic test
Briefly, new MRI sequences will be used on a patient who is undergoing a scheduled, clinically necessary MRI exam. Any new research sequence will be scanned in addition to the clinically required sequences and will not interfere with the clinical scan other than requiring five to ten minutes of additional "table time". There will be no invasive measures under this protocol.
| Study group | Role | What they receive |
|---|---|---|
| Study Participants | Patients of any age, including males and females, who are being treated in the Department of Pediatrics and are already scheduled to undergo MRI Receives: Diagnostic Test: MRI |
What is being measured
The primary outcome is the main question the study is designed to answer.
Compare Image Quality
To assess the new MRI sequences or MRI analysis methods and compare their image quality to current clinical ones. Specifically, we aim to compare the routine sequences with the experimental sequences.
Measured: Day of MRI
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2020
- Study start18 Nov 2020
- Primary completion18 Nov 2026 (estimated)
- Study completion18 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pediatric DisorderStudies of the same condition, open and under way.
- More trials run by Memorial Sloan Kettering Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 21 participants (actual)
Sponsor and investigators
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gerald Behr, MD, Principal investigator, Memorial Sloan Kettering Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04643015
- Sponsor's protocol ID
- 20-482
- Status last verified
- Sep 2026
- First submitted
- 19 Nov 2020
- Last updated
- 3 Sep 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.